Scientists have found that vitamin D functions to reduce inflammation caused by immune cells that might be relevant to the responses during severe COVID-19.
These are important cells of the immune system and implicated as part of the immune response to the infection causing COVID-19.
The team led by Purdue University studied and analysed individual lung cells from eight people with COVID.
Finding that viruses can trigger a biochemical pathway, known as the immune complement system, the researchers started looking for ways to disrupt that pathway and ameliorate the subsequent inflammation.
"In normal infections, Th1 cells, a subset of T cells, go through a pro-inflammatory phase," said Majid Kazemian, assistant professor in the departments of Computer Science and Biochemistry at Purdue University.
In patients with COVID-19, the pro-inflammatory phase of the Th1 cells seems not switched off, possibly because the patients didn't have enough vitamin D in their system or because something about the cell's response to vitamin D was abnormal.
In that case, the researchers posit, adding vitamin D to existing treatments in the form of a prescribed highly concentrated intravenous metabolite may further help people recover from COVID infections, though they have not tested this theory.
"We do not recommend the use of normal vitamin D off the shelf at the pharmacy. No one should be taking more than the recommended doses of vitamin D in an attempt to prevent or combat COVID infections."
Further research, especially clinical trials, and testing in patients, are necessary before this can be adopted as a treatment option, Kazemian said.
(This story was published from a syndicated feed. Only the headline and picture has been edited by FIT)
(At The Quint, we are answerable only to our audience. Play an active role in shaping our journalism by becoming a member. Because the truth is worth it.)